Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol (Nantheia ATL5) for PTSD in Adults
NCT05269459Phase 2Recruiting
- Sponsor
- University of Nebraska
- Start
- Dec 2022
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in post-traumatic stress disorder (PTSD), sponsored by University of Nebraska. Started Dec 2022; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT05269459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05269459.